Intra-Cellular Therapies
ITCI
#1264
Rank
NZ$23.62 B
Marketcap
$221.78
Share price
0.00%
Change (1 day)
77.91%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.60

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.71. In 2022 the company made an earnings per share (EPS) of -$4.57 an increase over its 2021 EPS that were of -$5.89.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.60-43.14%
2022-$4.57-22.29%
2021-$5.898.02%
2020-$5.4520.9%
2019-$4.51-5.63%
2018-$4.7833.96%
2017-$3.57-21.19%
2016-$4.52-7.56%
2015-$4.89174.53%
2014-$1.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.42-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$16.82 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.60 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA